Table 3 New Melanoma Patient Sera Analysis
From: Multiplex serum biomarker assessments: technical and biostatistical issues
Sample | Draw Date | Assay Date | IL-4 pg/mL | IL-6 pg/mL | IL-8 pg/mL | IL-10 pg/mL | TNF-α pg/mL | IFN-g pg/mL | GM-CSF pg/mL | IP-10 pg/mL | MIG pg/mL | MCP-1 pg/mL |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mel. Pt. 1 | 5/10/2010 | 5/13/2010 | 15 | 11 | 42 | < 14 | 95 | 24 | < 15 | 39 | 12 | 754 |
5/10/2010 | 5/13/2010 | 10 | 8 | 39 | < 14 | 82 | 22 | < 15 | 40 | 17 | 754 | |
5/10/2010 | 8/11/2010 | 21 | 12 | 44 | 22 | 183 | 20 | 41 | 49 | 32 | 270 | |
5/10/2010 | 8/11/2010 | 24 | 13 | 43 | 29 | 168 | 23 | 51 | 50 | 32 | 268 | |
Mel. Pt. 2 | 5/10/2010 | 5/13/2010 | 18 | 17 | 87 | < 14 | < 10 | 26 | < 15 | 30 | 21 | 1437 |
5/10/2010 | 5/13/2010 | 13 | 16 | 95 | < 14 | < 10 | 21 | < 15 | 31 | 17 | 1494 | |
5/10/2010 | 8/11/2010 | 28 | 30 | 97 | 22 | 10 | 25 | 33 | 38 | 39 | 664 | |
5/10/2010 | 8/11/2010 | 25 | 31 | 86 | 24 | 10 | 24 | 30 | 37 | 28 | 662 | |
Mel. Pt. 3 | 5/10/2010 | 5/13/2010 | 42 | 21 | 72 | 29 | 20 | < 12 | 18 | 190 | 81 | 771 |
5/10/2010 | 5/13/2010 | 38 | 19 | 70 | 25 | 17 | < 12 | 18 | 188 | 78 | 732 | |
5/10/2010 | 8/11/2010 | 34 | 14 | 73 | 31 | 38 | 9 | 47 | 141 | 96 | 223 | |
5/10/2010 | 8/11/2010 | 36 | 15 | 70 | 28 | 32 | 6 | 50 | 135 | 89 | 198 | |
Mel. Pt. 4 | 5/10/2010 | 5/13/2010 | 68 | 26 | 45 | 51 | 19 | 62 | 107 | 19 | 145 | 955 |
5/10/2010 | 5/13/2010 | 66 | 24 | 42 | 53 | 18 | 63 | 111 | 18 | 143 | 875 | |
5/10/2010 | 8/11/2010 | 102 | 36 | 26 | 120 | < 10 | 16 | 50 | 19 | 100 | 238 | |
5/10/2010 | 8/11/2010 | 99 | 41 | 24 | 139 | < 10 | 16 | 48 | 20 | 103 | 215 | |
Mel. Pt. 5 | 5/10/2010 | 5/13/2010 | 35 | 64 | 380 | < 14 | 13 | 27 | 78 | 27 | 106 | 831 |
5/10/2010 | 5/13/2010 | 34 | 61 | 393 | < 14 | 10 | 27 | 82 | 26 | 101 | 737 | |
5/10/2010 | 8/11/2010 | 33 | 43 | 458 | 20 | 16 | 27 | 54 | 32 | 139 | 170 | |
5/10/2010 | 8/11/2010 | 45 | 53 | 480 | 25 | 24 | 34 | 55 | 38 | 146 | 222 |